- Book
- January 2016
- 472 Pages
- Book
- April 2015
- 344 Pages
- Book
- March 2015
- 256 Pages
- Book
- January 2015
- 600 Pages
- Book
- July 2014
- 320 Pages
- Book
- March 2014
- 312 Pages
- Book
- January 2014
- 432 Pages
- Book
- November 2013
- 744 Pages
- Book
- October 2013
- 488 Pages
- Book
- August 2013
- 624 Pages
- Book
- April 2013
- 488 Pages
Global
- Book
- January 2013
- 352 Pages
- Book
- July 2012
- 542 Pages
- Book
- June 2012
- 412 Pages
- Book
- April 2012
- 268 Pages
- Book
- March 2012
- 450 Pages
- Book
- March 2012
- 544 Pages
- Book
- January 2012
- 560 Pages
- Book
- January 2011
- 520 Pages
- Book
- January 2011
- 1022 Pages
The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more